FidoCure by the One Health Company and Stanford University Research Shared at AACR 2024 We are excited to announce that our pioneering study on the PARP inhibitor, conducted in collaboration with the esteemed James Zou and his research team from Stanford University, was showcased by Dr. Lucas Rodrigues at the 2024 Annual Meeting of the […]